02289nam a2200445 i 4500001001300000003000600013005001700019007001400036008004100050040002800091042000800119043001200127050002100139074001600160086002100176088008600197099002100283110012700304245025500431246005700686264006000743300002700803336000800830337001600838338001900854500003600873504004100909500002400950500002500974533010600999610007201105650007101177650007101248650003301319650005801352655003301410776019001443776019101633999001901824on1061559561OCoLC20181217092328.0he bmb024bbca181107s2018    dcu     bb   f000 0 eng c  aGPObengerdacGPOdMvI  apcc  an-us--- 4aKF27b.V462 2017  a1027-B (MF)0 aY 4.V 64/3:115-4  aSerial no. 115-4 (United States. Congress. House. Committee on Veterans' Affairs)  aY 4.V 64/3:115-41 aUnited States.bCongress.bHouse.bCommittee on Veterans' Affairs.bSubcommittee on Oversight and Investigations,eauthor.10aAssessing VA's risks for drug diversion :bhearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Fifteenth Congress, first session, Monday, February 27, 2017.3 aAssessing Veterans Affairs' risks for drug diversion 1aWashington :bU.S. Government Publishing Office,c2018.  aiii, 41 pages ;c24 cm  btxt  bh2rdamedia  bhe2rdacarrier  aShipping list no.: 2018-0188-M.  aIncludes bibliographical references.  a"Serial no. 115-4."  aCRDP Program record.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.10aUnited States.bVeterans Health AdministrationxRules and practice. 0aHospital pharmaciesxSecurity measureszUnited StatesxEvaluation. 0aVeterans' hospitalsxSecurity measureszUnited StatesxEvaluation. 0aOpioid abusezUnited States. 0aDrugsxPrescribingxCorrupt practiceszUnited States. 7aLegislative hearings.2lcgft08iPrint version:aUnited States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations.tAssessing VA's risks for drug diversionw(OCoLC)103907992208iOnline version:aUnited States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations.tAssessing VA's risks for drug diversionw(OCoLC)1039079947  c277147d277147